Zhejiang Hisun Biomaterials Co., Ltd. was established.

30 tons/year PLA trial facility was built and put into operation, and small-scale production process chain of PLA has been preliminarily mastered.

5,000 tons/year PLA production line was completed and achieved stable production, which laid foundation for the 10,000-ton polylactic acid production line.

Build a polylactic acid production line with an annual output of 10,000 tons and a processing and modification production line for related products.

Phase I (30kt/a) of subsidiary Honor's 50kt/a PLA project was commissioned in December.

Hisun Biomaterials was listed in SSE STAR MARKET(stock code: 688203) .

Phase II (20kt/a) of subsidiary Honor's 50kt/a PLA project was commissioned in 2023.

Phase I (75kt/a) of subsidiary Hitrend's 150kt/a PLA project was officially commissioned in May 2026.